Cargando…

Highly efficient respirators are needed for the Omicron variant of SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Mattiuzzi, C., Lippi, G., Nocini, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society for Public Health. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930697/ https://www.ncbi.nlm.nih.gov/pubmed/35450730 http://dx.doi.org/10.1016/j.puhe.2022.03.003

Ejemplares similares

COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

Analysis of online search trends suggests that SARS-CoV-2 Omicron (B.1.1.529) variant causes different symptoms
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

COVID-19 vaccination is highly effective to prevent SARS-CoV-2 circulation
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

Has SARS-CoV-2 evolved and adapted to circulate at high temperatures?
por: Lippi, G., et al.
Publicado: (2022)

COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

High rate of reinfection with the SARS-CoV-2 Omicron variant
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

It is not the time to relax yet: masks are still needed for the Omicron variant of SARS-CoV-2
por: Lowe, Scott, et al.
Publicado: (2022)

Omicron variant in the current SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

Determinants of reinfection with SARS-CoV-2 Omicron variant
por: Bisharat, N., et al.
Publicado: (2023)

SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Improving Nasal Protection for Preventing SARS-CoV-2 Infection
por: Nocini, Riccardo, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
por: Li, Pengfei, et al.
Publicado: (2022)

What Is New With Omicron Variant of SARS-CoV-2 in Children?
por: Bittmann, Stefan, et al.
Publicado: (2022)

SARS‐CoV‐2 omicron variant: Could it be another threat?
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Impact of COVID-19 pandemic on the worldwide burden of tinnitus
por: Nocini, Riccardo, et al.
Publicado: (2022)

High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection
por: Zheng, Jing, et al.
Publicado: (2022)

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
por: Xia, Shuai, et al.
Publicado: (2022)

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab
por: Vellas, Camille, et al.
Publicado: (2022)

“Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants”
por: Vera-Lise, Ihm, et al.
Publicado: (2022)

Presentation and outcomes of SARS-CoV-2 Omicron variant infection in haemodialysis patients
por: Chimon, Alice, et al.
Publicado: (2022)

Two SARS-CoV-2 serology assays detect antibodies in the sera of individuals diagnosed with SARS-CoV-2 Omicron variant
por: Conklin, Justin, et al.
Publicado: (2022)

Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
por: Ahava, Maarit J., et al.
Publicado: (2022)

Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment
por: Vellas, Camille, et al.
Publicado: (2022)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

Letter to the editor: Epidemiology of the SARS-CoV-2 variant Omicron BA.2 – vigilance needed
por: Huang, Jing, et al.
Publicado: (2022)

Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant
por: Migueres, Marion, et al.
Publicado: (2022)

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
por: Zhang, Na-Na, et al.
Publicado: (2022)

5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2022)

The role of masks and respirator protection against SARS-CoV-2
por: Wang, Qiang, et al.
Publicado: (2020)

Size-dependent filtration efficiencies of face masks and respirators for removing SARS-CoV-2–laden aerosols
por: Liu, Yumeng, et al.
Publicado: (2020)

The presence of anti–SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Omicron: A SARS‐CoV‐2 variant of real concern
por: Gattinger, Pia, et al.
Publicado: (2022)

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates
por: Bojkova, Denisa, et al.
Publicado: (2022)

Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Assessment of the Analytical Sensitivity of 10 Lateral Flow Devices against the SARS-CoV-2 Omicron Variant
por: Deerain, Joshua, et al.
Publicado: (2022)

Cohorting inpatients with Omicron and Delta variants of Sars-CoV-2 does not increase rates of mixed infection
por: Davies, Jessica, et al.
Publicado: (2022)

Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1 variant in South Korea
por: Guo, Zihao, et al.
Publicado: (2022)

The efficacy and safety of IBI314 on delta and omicron variant of SARS-CoV-2: First-in-human evidence
por: Sang, Ling, et al.
Publicado: (2022)

Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
por: Taenaka, Ryutaro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_slojc4mdk1vd4onm28inv94ham